Kadant

KAI · NYSE

$264.81+$1.04 (+0.39%)TodayMarket closed ·
Prev close $263.77

KAI analyst rating

BuyConsensus of 2 analysts over the last 12 months. 50% rate it a buy.
  • Strong buy0
  • Buy1
  • Hold1
  • Underperform0
  • Sell0

12-month price target · 3 analysts

Average $364.65 (+37.7% upside)

Low
$338.35
Now
$264.81
High
$399.00

Upgrades and downgrades

The latest rating actions, newest first

KAI analyst upgrades, downgrades and rating actions
FirmDateActionRating
DA DavidsonAug 6, 2026MaintainsNeutral
Barrington ResearchMay 4, 2026MaintainsOutperform
Barrington ResearchFeb 24, 2026MaintainsOutperform
Barrington ResearchFeb 19, 2026MaintainsOutperform
Barrington ResearchFeb 18, 2026MaintainsOutperform
DA DavidsonFeb 9, 2026MaintainsNeutral
DA DavidsonFeb 4, 2026MaintainsNeutral
Barrington ResearchFeb 3, 2026MaintainsOutperform
Barrington ResearchOct 30, 2025MaintainsOutperform
Barrington ResearchOct 29, 2025MaintainsOutperform

The case for and against

Updated Aug 11, 2026

Bull case

Kadant is positioned for long-term success with its strong industry relationships, steady revenue and EPS growth, and potential for further expansion through acquisitions. The company's global operations present some risk, but their strong backlog and recent acquisition of voestalpine BÖHLER Profil GmbH & Co. demonstrate their ability to navigate challenges and continue to grow. With a solid financial position and a focus on returning value to shareholders, Kadant is a strong investment opportunity for those with a positive outlook on the process and engineering equipment industry.

Bear case

Kadant is facing challenges in its Flow Control and Industrial Processing segments as evidenced by their decline in organic revenue, as well as the impact of input cost increases and unfavorable customer mix. While acquisitions and demand for aftermarket parts have helped drive overall revenue growth, their margins are still under pressure due to these challenges. Additionally, North America, the company's largest market, is also showing signs of weakness with a decline in organic revenue and segment EBITDA.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.